Apogee Acquisition Corp Class A AACP 深 沪
等待开盘 07-03 09:30:00 美东时间
10.01
+0.030
+0.30%
华盛通- 最 高10.01
- 今 开10.00
- 成交量 6548股
- 最 低 10.00
- 昨 收 9.98
- 总市值 23.49万
- 52周最高 10.01
- 市盈率 静 --
- 换手率 27.90%
- 52周最低 9.93
- 委 比 -14.16%
- 总股本 2.35万
- 历史最高 10.01
- 量 比 0.47
- 振 幅 0.10%
- 历史最低 9.93
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Apogee Therapeutics signs financing deal with Blackstone Life Sciences for up to $1.3 billion
Apogee Therapeutics signs financing deal with Blackstone Life Sciences for up to $1.3 billion Apogee Therapeutics entered a strategic financing collaboration with Blackstone Life Sciences for up to USD 1.3 billion in non-dilutive capital. Package includes up to USD 800 million of synthetic royalty f
05-27 18:31
Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis
Apogee Therapeutics announced positive results from the Phase 2 APEX trial of zumilokibart in moderate-to-severe atopic dermatitis (AD), meeting primary and secondary endpoints with high statistical significance. Mid-dose zumilokibart showed the best clinical activity and tolerability, with plans for Phase 3 trials in 2H 2026. The drug demonstrated potential for less frequent dosing and robust efficacy, with plans to expand into asthma and eosino...
05-27 10:30
